Meta is expected to report better-than-feared earnings due to an improving digital ad market, making it an appealing stock to ...

Finding a better way to treat cancer, tackling the nursing shortage or just providing a better way to order tests are ...

AbbVie had a strong Q1 performance in its oncology, neuroscience, and immunology franchises. Read why I continue to rate ABBV ...

As April gives way to May, the market braces for a blockbuster week packed with earnings from some of the biggest names ...

With its 2-star rating, we believe Lilly stock is overvalued compared with our long-term fair value estimate of $650 per ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

(Reuters) -U.S. corporations have been ramping up their security spending, but following the murder of UnitedHealth (NYSE: UNH) executive Brian Thompson that expenditure is set to rise further in 2025 ...

European markets are set to start the trading week in positive territory, with investors anticipating major earnings and data ...

Baron Health Care Fund retreated in the first quarter of 2025, underperforming its benchmark, the Russell 3000 Health Care ...

Bamlanivimab and etesevimab combination has been authorised under Emergency Use Authorisation in the US and select EU countries for the treatment of the disease.